What Is the Best Way to Correct Astigmatism?
Title: What Is the Best Way to Correct Astigmatism?Category: Diseases and ConditionsCreated: 9/25/2020 12:00:00 AMLast Editorial Review: 9/25/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - September 25, 2020 Category: Opthalmology Source Type: news
Can PRK Surgery Correct Astigmatism?
Title: Can PRK Surgery Correct Astigmatism?Category: Procedures and TestsCreated: 9/24/2020 12:00:00 AMLast Editorial Review: 9/24/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - September 24, 2020 Category: Opthalmology Source Type: news
Bausch and Lomb Introduces enVista(R) Toric MX60ET Intraocular Lens With StableFlex(TM) Technology
New Hydrophobic Acrylic Toric IOL Combines Predictable Astigmatism Correction, Exceptional Rotational Stability, Controlled Unfolding and Improved Optical Recovery
BRIDGEWATER, N.J., Dec. 11, 2019 -- (Healthcare Sales & Marketing Network) -- Bausch & L... Devices, Ophthalmology, Product Launch Bausch & Lomb, Bausch Health Companies, enVista Toric, IOL (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 11, 2019 Category: Pharmaceuticals Source Type: news
The impact of uncorrected astigmatism on night driving performance - Black AA, Wood JM, Colorado LH, Collins MJ.
PURPOSE: To investigate the effect of uncorrected astigmatism on night driving performance on a closed-road circuit. METHODS: Participants included 10 drivers (mean age 24.4 ± 7.0 years), with low to moderate bilateral astigmatism (0.75-1.50 DC... (Source: SafetyLit)
Source: SafetyLit - August 8, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Bausch and Lomb ULTRA(R) Multifocal for Astigmatism Contact Lenses Now Available in the United States
New Lens is the Most Advanced Soft Contact Lens Design in Bausch & Lomb History
Only Multifocal Toric Lens that Offers Eye Care Professionals a Convenient Same-Day Fit to Address Patients with Astigmatism and Presbyopia
BRIDGEWATER, N.J., June 19, 2... Devices, Ophthalmology, Product Launch Bausch & Lomb, Bausch Health Companies, ULTRA Multifocal, astigmatism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2019 Category: Pharmaceuticals Source Type: news
FDA approves eye surgery KC-area doctor helped develop
The Food and Drug Administration has approved an advancement in eye surgery developed and tested by five doctors nationwide, one of whom is Kansas City-based Dr. John Doane.
Small Incision Lenticule Extraction (SMILE) is a minimally invasive procedure first approved in 2016 for patients with nearsightedness.
The FDA approved the s urgery for people with astigmatism in October, expanding the procedure’s scope to more than 90 percent of the population seeking vision correction, Doane… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2018 Category: Biotechnology Authors: Lily Lieberman Source Type: news
FDA approves eye surgery KC-area doctor helped develop
The Food and Drug Administration has approved an advancement in eye surgery developed and tested by five doctors nationwide, one of whom is Kansas City-based Dr. John Doane.
Small Incision Lenticule Extraction (SMILE) is a minimally invasive procedure first approved in 2016 for patients with nearsightedness.
The FDA approved the s urgery for people with astigmatism in October, expanding the procedure’s scope to more than 90 percent of the population seeking vision correction, Doane… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 10, 2018 Category: Pharmaceuticals Authors: Lily Lieberman Source Type: news
Bausch and Lomb Receives 510(K) Clearance From FDA For Bausch and Lomb Ultra(R) Multifocal For Astigmatism Contact Lenses
BRIDGEWATER, N.J., Dec. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Bausch & Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that it has received 510(k) cleara... Devices, Ophthalmology, FDA Bausch & Lomb, Ultra Multifocal, Astigmatism, Contact Lens (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 5, 2018 Category: Pharmaceuticals Source Type: news
Staar Surgical shares jump on Q3 Beat
Shares in Staar Surgical (NSDQ:STAA) have risen in after-hours trading today after the medical device maker beat expectations on Wall Street with its third quarter results.
The Monrovia, Calif.-based company posted profits of approximately $1.5 million, or 3¢ per share, on sales of approximately $31.8 million for the three months ended September 28, for bottom-line growth of 24.4% on sales growth of 35.3% compared with the same period during the previous year.
Adjusted to exclude one time items, earnings per share were 7¢, well ahead of the 3¢ loss-per-share expectation on Wall Street, where analysts expected to see sa...
Source: Mass Device - October 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat STAAR Surgical Co Source Type: news
Newly Approved Toric ICL Implanted in First US Patient Newly Approved Toric ICL Implanted in First US Patient
A 37-year-old Illinois truck driver has become the first person in the United States to receive new implantable lenses for the correction of myopia with astigmatism approved by the US Food and Drug Administration last month.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 26, 2018 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news
Clerio Vision launches first-in-man trial of Liric laser vision correction
Early stage opthalmalogical device maker Clerio Vision said today it launched a first-in-human trial of its Liric non-invasive vision correction system and associated procedure, and that it already enrolled and treated five subjects in the study.
The system uses femtosecond laser technology developed by Gerard Mourou and Donna Strickland at the University of Rochester intended to change the refractive index of corneal tissue to correct nearsightedness, farsightedness, astigmatism and presbyopia.
“In addition to being able to offer a noninvasive vision correction alternative to patients concerned about surgery, we are...
Source: Mass Device - October 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Optical/Ophthalmic Clerio Vision Source Type: news
Carl Zeiss Meditec wins FDA nod for ReLEx SMILE
Carl Zeiss Meditec (ETR:AFX) said today it won FDA premarket approval for its ReLEx Smile laser system intended for ophthalmological use.
The German company said that with the approval, its ReLEx Smile system is now cleared for patients with astigmatism. The approval also allows for a small entry incision to be made, allowing the company’s Smile procedure to be less disruptive to the corneal surface tissue.
“The expansion of Myopia treatment to patients with Astigmatism will enable current and future Smile surgeons to expand their patient base, paving the way for a new generation of refractive surgery patient...
Source: Mass Device - October 5, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Pre-Market Approval (PMA) Regulatory/Compliance Carl Zeiss Meditec Source Type: news
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
Small Incision Lenticule Extraction, better known as ReLEx SMILE from ZEISS is a minimally-invasive corneal refractive procedure performed on the ZEISS VisuMax femtosecond laser
DUBLIN, Calif., Oct. 5, 2018 -- (Healthcare Sales & Marketing Network) -- ... Devices, Ophthalmology, FDA ZEISS, ReLEx SMILE, myopia, astigmatism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 5, 2018 Category: Pharmaceuticals Source Type: news
Staar Surgical wins FDA nod for Visian Toric ICL
Staar Surgical (NSDQ:STAA) said yesterday that it won FDA approval for its Visian toric implantable collamer lens designed for correcting myopia with astigmatism.
The Monrovia, Calif.-based company said that with the approval, its ICL product line is now cleared for the correction of refractive errors in patients with both myopia and astigmatism.
Staar Surgical said that its ICLs in both spherical and toric designs have been associated with “significant improvements in quality of life,” and touted that patients who’ve received ICL surgery as “life changing,” according to a press release.
...
Source: Mass Device - September 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Regulatory/Compliance STAAR Surgical Co Source Type: news
Endothelial Cell Density After Iris-Fixated Phakic IOL Endothelial Cell Density After Iris-Fixated Phakic IOL
How common is endothelial cell loss after implantation of iris-fixated phakic intraocular lenses in myopia and astigmatism? Not uncommon at all, says Dr Christopher Rapuano.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2018 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news
